Norinchukin Bank The Purchases 5,371 Shares of Synopsys, Inc. $SNPS

Key Points

• Norinchukin Bank The increased its holdings in Synopsys, Inc. by 46.9% during the first quarter, owning 16,826 shares valued at $7,216,000.
• Synopsys has received multiple new price targets from analysts, with Goldman Sachs setting a target of $620.00 and Morgan Stanley raising theirs to $715.00.
• Insider trading activity revealed that Synopsys executives sold a significant number of shares, with the CRO selling 9,010 shares for over $4.2 million, marking an 85.85% decrease in their ownership.

Norinchukin Bank The boosted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 46.9% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 16,826 shares of the semiconductor company's stock after purchasing an additional 5,371 shares during the period. Norinchukin Bank The's holdings in Synopsys were worth $7,216,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. CW Advisors LLC increased its position in Synopsys by 3.0% in the first quarter. CW Advisors LLC now owns 38,263 shares of the semiconductor company's stock worth $16,410,000 after buying an additional 1,102 shares in the last quarter. Brown Shipley& Co Ltd increased its position in Synopsys by 54.7% in the first quarter. Brown Shipley& Co Ltd now owns 15,151 shares of the semiconductor company's stock worth $6,498,000 after buying an additional 5,356 shares in the last quarter. United Asset Strategies Inc. increased its position in Synopsys by 7.1% in the first quarter. United Asset Strategies Inc. now owns 2,183 shares of the semiconductor company's stock worth $936,000 after buying an additional 144 shares in the last quarter. Partners Capital Investment Group LLP purchased a new stake in Synopsys in the first quarter worth about $37,938,000. Finally, Accredited Wealth Management LLC purchased a new stake in Synopsys in the first quarter worth about $52,000. Hedge funds and other institutional investors own 85.47% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on SNPS shares. Piper Sandler upped their price target on Synopsys from $615.00 to $660.00 and gave the stock an "overweight" rating in a research report on Monday, July 21st. Stifel Nicolaus set a $550.00 price target on Synopsys in a report on Monday, April 28th. KeyCorp raised their price target on Synopsys from $540.00 to $610.00 and gave the company an "overweight" rating in a report on Thursday, July 10th. Rosenblatt Securities raised their price target on Synopsys from $625.00 to $650.00 and gave the company a "buy" rating in a report on Friday, July 25th. Finally, Morgan Stanley reissued an "overweight" rating and set a $715.00 price target (up from $540.00) on shares of Synopsys in a report on Monday, August 11th. Twelve investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $626.79.

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 7,310 shares of the stock in a transaction on Friday, June 6th. The stock was sold at an average price of $485.72, for a total value of $3,550,613.20. Following the sale, the chief financial officer owned 15,291 shares in the company, valued at $7,427,144.52. This trade represents a 32.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CRO Richard S. Mahoney sold 9,010 shares of the business's stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total transaction of $4,245,602.10. Following the sale, the executive directly owned 1,485 shares of the company's stock, valued at $699,746.85. This represents a 85.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 27,686 shares of company stock valued at $13,001,048 over the last three months. 0.62% of the stock is owned by company insiders.

Synopsys Price Performance

SNPS stock traded up $8.35 during trading on Friday, hitting $606.52. 863,153 shares of the company's stock traded hands, compared to its average volume of 1,265,589. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The company has a debt-to-equity ratio of 1.01, a quick ratio of 6.85 and a current ratio of 7.02. The business has a fifty day simple moving average of $570.29 and a 200 day simple moving average of $500.54. The stock has a market capitalization of $94.11 billion, a price-to-earnings ratio of 43.79, a P/E/G ratio of 3.99 and a beta of 1.15.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 EPS for the quarter, beating the consensus estimate of $3.40 by $0.27. Synopsys had a net margin of 34.77% and a return on equity of 17.09%. The business had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.60 billion. During the same quarter last year, the business earned $3.00 earnings per share. Synopsys's quarterly revenue was up 10.3% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. As a group, research analysts expect that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.